1TT.F · Factor Therapeutics Limited

-

Please sign in to comment on 1TT.F

1 Comment

Admin

3 years, 7 months ago

Factor Therapeutics Limited is currently in a long term uptrend where the price is trading 87.1% above its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Its net income has dropped by 0.0% to $-179K since the same quarter in the previous year.

Finally, its free cash flow grew by 22.1% to $-125K since the same quarter in the previous year.

Based on the above factors, Factor Therapeutics Limited gets an overall score of 3/5.

Sector	Healthcare
Industry	Biotechnology
ISIN	None
CurrencyCode	EUR
Exchange	F

Dividend Yield	0.0%
Target Price	None
Beta	0.48
Market Cap	52M
PE Ratio	0.0

ABOUT

Factor Therapeutics Limited

Dominion Minerals Limited, together with its subsidiary, engages in the exploration of mineral properties. It holds an option to purchase a high calcium limestone project located in Early County, south Georgia. The company was formerly known as Factor Therapeutics Limited and changed its name to Dominion Minerals Limited in September 2021. Dominion Minerals Limited was incorporated in 2002 and is based in Brisbane, Australia.

1TT.F · Factor Therapeutics Limited

-

Factor Therapeutics Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Factor Therapeutics Limited using a moving average strategy